Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients / 감염과화학요법
Infection and Chemotherapy
;
: 792-795, 2021.
Article
in English
| WPRIM
| ID: wpr-914615
ABSTRACT
Tuberculosis (TB) is a common opportunistic infection in human immunodeficiency virus (HIV)-infected patients. Patients with multidrug-resistant (MDR)-TB have poor outcomes.This study aimed to determine the prevalence of MDR-TB in HIV/TB co-infected patients in the Korea. We reviewed the medical records of HIV/TB co-infected patients at two university hospitals between January 1998 and December 2020. During the study period, a total of 87 HIV/TB co-infected patients were identified, and drug susceptibility test results were available for 44 of them. The prevalence of MDR-TB in the study population was 15.9% (7/44, 95% confidence interval, 5.1 - 26.7).
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prevalence study
Language:
English
Journal:
Infection and Chemotherapy
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS